A preliminary study demonstrates a machine learning approach for predicting local control in lung cancer, suggesting further validation is essential.
ML demonstrates certain potential in LC prediction after SBRT. Nevertheless, it is worth noting that the study relies solely on internal validation and lacks external validation; therefore, further validation in independent cohorts is required before the model can be responsibly considered for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: